|
|
|
Volumn 25, Issue 6, 1998, Pages 623-635
|
|
Perspective on allogeneic melanoma lysates in active specific immunotherapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA2B INTERFERON;
CYCLOPHOSPHAMIDE;
IMMUNOMODULATING AGENT;
MELACINE;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
MELANOMA;
PRIORITY JOURNAL;
REVIEW;
ANTIGENS, NEOPLASM;
ANTINEOPLASTIC AGENTS;
CANCER VACCINES;
CLINICAL TRIALS;
EPITOPES;
HUMANS;
IMMUNOTHERAPY, ACTIVE;
INTERFERON ALFA-2B;
MELANOMA;
T-LYMPHOCYTES, CYTOTOXIC;
TUMOR CELLS, CULTURED;
|
|
EID: 0031648808
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (118)
|
|
References (29)
|
